M&T Bank’s Insys Therapeutics, Inc. INSY Stock Holding History

M&T Bank’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-7,555	Closed	-$216K	–	1839
2015 Q4	$216K	Buy	+7,555	New	+$209K	﹤0.01%	1470
2015 Q3	–	Sell	-27,564	Closed	-$990K	–	2109
2015 Q2	$990K	Buy	27,564 +302	+1%	+$9.41K	0.01%	897
2015 Q1	$792K	Sell	27,262 -1,652	-6%	-$43.7K	﹤0.01%	969
2014 Q4	$610K	Sell	28,914 -74,354	-72%	-$1.47M	﹤0.01%	1099
2014 Q3	$2M	Buy	+103,268	New	+$1.62M	0.01%	610

Other funds holding INSY

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FHAM

Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

M&T Bank's INSY Position: Q1 2016 in Review

M&T Bank sold out of Insys Therapeutics, Inc. (INSY) in Q1 2016, closing a stake of 7,555 shares — an estimated $216K sold.

M&T Bank first reported a position in INSY in Q3 2014 and held it in 5 quarters. The position peaked at $2M in Q3 2014. 138 funds tracked by Wall St. Rank hold INSY as of Q1 2016.

M&T Bank reported no remaining Insys Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
M&T Bank sold 7,555 Insys Therapeutics, Inc. shares in Q1 2016, an estimated $216K.
M&T Bank first reported a position in Insys Therapeutics, Inc. in Q3 2014 and held it in 5 quarters.
M&T Bank's Insys Therapeutics, Inc. position peaked at $2M in Q3 2014.
138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2016.

Based on M&T Bank's 13F filing for Q1 2016, filed 11 May 2016.